| Dr William Veverka, DPT | |
|
1730 Kingsley Ave, Akron, OH 44313-6109 | |
| (330) 571-7901 | |
| Not Available |
| Full Name | Dr William Veverka |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 1730 Kingsley Ave, Akron, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356872923 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT016569 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr William Veverka, DPT 1730 Kingsley Ave, Akron, OH 44313-6109 Ph: (330) 571-7901 | Dr William Veverka, DPT 1730 Kingsley Ave, Akron, OH 44313-6109 Ph: (330) 571-7901 |
News Archive
A new optical instrument that could vastly reduce the amount of time the pharmaceutical industry spends in R&D, by speeding up the measurement of drug inhaler performance, is being launched by Loughborough University spin out VariDose Limited.
OptiScan Biomedical Corporation, a developer of innovative continuous glucose monitoring systems for use in intensive care units (ICU), today announced that the company's OptiScanner Automatic Bedside Glucose Monitoring System has received CE Mark certification for use in the European Union.
Pearl Therapeutics Inc., a company developing clinically differentiated double and triple combination therapies for the treatment of highly prevalent chronic respiratory diseases, presented results from four studies that provide support for further development of PT003, the company's fixed dose combination of glycopyrrolate and formoterol delivered via a pressurized hydrofluoroalkane metered dose inhaler (HFA-MDI).
As the Zika virus captures headlines across the United States, with its possible link to birth defects and the first cases reported in the U.S. (all traced back to overseas travel), it's an opportune time to review the facts associated with this disease.
House Democrats plan to introduce bills that would reduce restrictions on federal funding for embryonic stem cell research and allow HHS to negotiate directly with pharmaceutical companies on prices for medications under the Medicare prescription drug benefit, incoming House Majority Leader Steny Hoyer (D-Md.) said on Wednesday, CQ Today reports.
› Verified 7 days ago
Kathy J Peterson, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 640 W Market St, Akron, OH 44303 Phone: 330-762-5425 | |
Cortney Ann Myer, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-2110 | |
Rehabilitation And Health Center Inc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1799 Akron Peninsula Rd, Suite 312, Akron, OH 44313 Phone: 330-752-7265 | |
Dr. Brenda Renee Runion, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 400 Wabash Ave, Akron, OH 44307 Phone: 330-344-6190 | |
Dr. Michael John Golz, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 525 E Market St, Akron, OH 44304 Phone: 330-375-4854 Fax: 330-375-4074 | |
Lisa Dietsche, P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 640 W Market St, Akron, OH 44303 Phone: 330-762-5425 | |
Michael Green, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 525 E Market St, Akron, OH 44304 Phone: 330-375-3367 |